vs
Assertio Holdings, Inc.（ASRT）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Assertio Holdings, Inc.的1.0倍（$14.0M vs $13.5M），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -57.9%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
ASRT vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.0倍
$13.5M
营收增速更快
RVSB
高出68.3%
-57.9%
两年增速更快
RVSB
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $14.0M |
| 净利润 | — | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 12.4% |
| 净利率 | — | 9.8% |
| 营收同比 | -57.9% | 10.4% |
| 净利润同比 | — | 11.8% |
| 每股收益（稀释后） | $-4.54 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTRVSB
| Q4 25 | $13.5M | $14.0M | ||
| Q3 25 | $49.5M | $13.6M | ||
| Q2 25 | $29.2M | $13.3M | ||
| Q1 25 | $26.5M | $12.9M | ||
| Q4 24 | $32.2M | $12.7M | ||
| Q3 24 | $29.2M | $12.8M | ||
| Q2 24 | $31.1M | $12.2M | ||
| Q1 24 | $32.4M | $9.0M |
净利润ASRTRVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | $11.4M | $1.1M | ||
| Q2 25 | $-16.4M | $1.2M | ||
| Q1 25 | $-13.5M | $1.1M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $-2.9M | $1.6M | ||
| Q2 24 | $-3.7M | $966.0K | ||
| Q1 24 | $-4.5M | $-3.0M |
营业利润率ASRTRVSB
| Q4 25 | -86.7% | 12.4% | ||
| Q3 25 | 23.2% | 10.2% | ||
| Q2 25 | -27.5% | 11.7% | ||
| Q1 25 | -50.0% | 11.3% | ||
| Q4 24 | -41.9% | 12.4% | ||
| Q3 24 | -10.4% | 15.5% | ||
| Q2 24 | -11.6% | 10.0% | ||
| Q1 24 | -13.4% | -47.5% |
净利率ASRTRVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | 23.1% | 8.1% | ||
| Q2 25 | -56.0% | 9.2% | ||
| Q1 25 | -51.1% | 8.9% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -10.0% | 12.2% | ||
| Q2 24 | -11.8% | 7.9% | ||
| Q1 24 | -13.9% | -34.7% |
每股收益（稀释后）ASRTRVSB
| Q4 25 | $-4.54 | $0.07 | ||
| Q3 25 | $0.11 | $0.05 | ||
| Q2 25 | $-0.17 | $0.06 | ||
| Q1 25 | $-0.14 | $0.05 | ||
| Q4 24 | $-3.28 | $0.06 | ||
| Q3 24 | $-0.03 | $0.07 | ||
| Q2 24 | $-0.04 | $0.05 | ||
| Q1 24 | $-0.05 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $164.2M |
| 总资产 | $267.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTRVSB
| Q4 25 | $63.4M | $28.6M | ||
| Q3 25 | $93.4M | $32.8M | ||
| Q2 25 | $98.2M | $34.2M | ||
| Q1 25 | $87.3M | $29.4M | ||
| Q4 24 | $100.1M | $25.3M | ||
| Q3 24 | $88.6M | $31.0M | ||
| Q2 24 | $88.4M | $27.8M | ||
| Q1 24 | $80.7M | $23.6M |
总债务ASRTRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTRVSB
| Q4 25 | $94.0M | $164.2M | ||
| Q3 25 | $105.8M | $163.5M | ||
| Q2 25 | $93.3M | $162.0M | ||
| Q1 25 | $108.5M | $160.0M | ||
| Q4 24 | $121.1M | $158.3M | ||
| Q3 24 | $130.5M | $160.8M | ||
| Q2 24 | $132.2M | $155.9M | ||
| Q1 24 | $134.5M | $155.6M |
总资产ASRTRVSB
| Q4 25 | $267.0M | $1.5B | ||
| Q3 25 | $319.8M | $1.5B | ||
| Q2 25 | $273.8M | $1.5B | ||
| Q1 25 | $286.4M | $1.5B | ||
| Q4 24 | $284.7M | $1.5B | ||
| Q3 24 | $276.0M | $1.5B | ||
| Q2 24 | $279.4M | $1.5B | ||
| Q1 24 | $282.0M | $1.5B |
负债/权益比ASRTRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流ASRTRVSB
| Q4 25 | $-30.0M | $-506.0K | ||
| Q3 25 | $-4.8M | $16.8M | ||
| Q2 25 | $19.1M | $-697.0K | ||
| Q1 25 | $-12.5M | $8.3M | ||
| Q4 24 | $11.5M | $2.2M | ||
| Q3 24 | $-35.0K | $764.0K | ||
| Q2 24 | $7.4M | $5.4M | ||
| Q1 24 | $7.5M | $12.8M |
自由现金流ASRTRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率ASRTRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度ASRTRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.0% | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率ASRTRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | -0.42× | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
RVSB
暂无分部数据
